Novartis Ag (NVS) Inventory Average (2016 - 2025)
Historic Inventory Average for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $6.3 billion.
- Novartis Ag's Inventory Average rose 881.5% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year increase of 881.5%. This contributed to the annual value of $6.0 billion for FY2025, which is 305.95% up from last year.
- Novartis Ag's Inventory Average amounted to $6.3 billion in Q4 2025, which was up 881.5% from $6.4 billion recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Inventory Average ranged from a high of $8.1 billion in Q2 2023 and a low of $5.7 billion during Q2 2024
- In the last 5 years, Novartis Ag's Inventory Average had a median value of $6.8 billion in 2021 and averaged $6.6 billion.
- In the last 5 years, Novartis Ag's Inventory Average skyrocketed by 13290.47% in 2021 and then tumbled by 2869.55% in 2024.
- Quarter analysis of 5 years shows Novartis Ag's Inventory Average stood at $6.8 billion in 2021, then rose by 2.97% to $7.0 billion in 2022, then dropped by 17.42% to $5.8 billion in 2023, then rose by 1.21% to $5.8 billion in 2024, then grew by 8.81% to $6.3 billion in 2025.
- Its last three reported values are $6.3 billion in Q4 2025, $6.4 billion for Q3 2025, and $6.1 billion during Q2 2025.